Age
Item
male or female, age 18-65 years
boolean
C0001779 (UMLS CUI [1])
Schizophrenia | Schizophreniform Disorders
Item
participant must meet the diagnostic criteria for schizophrenia or schizophreniform disorder according to diagnostic and statistical manual of mental disorders, fourth edition (dsm-iv)-tm
boolean
C0036341 (UMLS CUI [1])
C0036358 (UMLS CUI [2])
Disease length
Item
total course of disease no more than 5 years
boolean
C0872146 (UMLS CUI [1])
Risperidone Injection Active Long-term | Atypical antipsychotic
Item
according to physician's discretion, participants need to be changed to risperidone long-acting injection and other atypical anti-psychotic drug
boolean
C4084406 (UMLS CUI [1,1])
C0205177 (UMLS CUI [1,2])
C0443252 (UMLS CUI [1,3])
C1276996 (UMLS CUI [2])
Informed Consent | Informed Consent Patient Representatives | Comprehension Study Protocol
Item
participant or their legally acceptable representatives must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
C0162340 (UMLS CUI [3,1])
C2348563 (UMLS CUI [3,2])
At risk Suicidal behavior | At risk Physical aggression
Item
significant risk of suicidal or violent behavior, as clinically assessed by the investigator
boolean
C1444641 (UMLS CUI [1,1])
C1760428 (UMLS CUI [1,2])
C1444641 (UMLS CUI [2,1])
C0424323 (UMLS CUI [2,2])
Aggressive behavior | Behavior Excited | Restless behavior
Item
have aggressive behavior and excited , restless
boolean
C0001807 (UMLS CUI [1])
C0004927 (UMLS CUI [2,1])
C3833702 (UMLS CUI [2,2])
C0237280 (UMLS CUI [3])
Tardive Dyskinesia | Symptoms Tardive Dyskinesia | Neuroleptic Malignant Syndrome | Liver Dysfunction | Abnormal renal function | Physical illness Severe | Drug Allergy Severe Life Threatening
Item
history or current symptoms of tardive dyskinesia; neuroleptic malignant syndrome; evidence of dysfunction of liver and kidney and other severe physical diseases; and severe, life-threatening allergic reaction to any drug
boolean
C0686347 (UMLS CUI [1])
C1457887 (UMLS CUI [2,1])
C0686347 (UMLS CUI [2,2])
C0027849 (UMLS CUI [3])
C0086565 (UMLS CUI [4])
C0151746 (UMLS CUI [5])
C0683323 (UMLS CUI [6,1])
C0205082 (UMLS CUI [6,2])
C0013182 (UMLS CUI [7,1])
C0205082 (UMLS CUI [7,2])
C2826244 (UMLS CUI [7,3])
Risperidone allergy
Item
known hypersensitivity to risperidone
boolean
C0570837 (UMLS CUI [1])
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
female participant who is pregnant or breastfeeding or planning to become pregnant during the study period
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])